Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015:2015:594970.
doi: 10.1155/2015/594970. Epub 2015 Apr 16.

Extramedullary hematopoiesis in a sentinel lymph node as an early sign of chronic myelomonocytic leukemia

Affiliations

Extramedullary hematopoiesis in a sentinel lymph node as an early sign of chronic myelomonocytic leukemia

Joslin M Bowen et al. Case Rep Pathol. 2015.

Abstract

Chronic myelomonocytic leukemia (CMML) is a clonal hematopoietic malignancy with features of both a myeloproliferative neoplasm and a myelodysplastic syndrome. Even though extramedullary leukemic infiltration is common in CMML patients, lymph node involvement has rarely been reported in the literature. We present an unusual case of a 72-year-old female who was found to have extramedullary hematopoiesis (EMH) in a sentinel lymph node that was excised during mastectomy for lobular breast carcinoma. One year later bone marrow biopsy was performed due to persistent anemia, thrombocytopenia, and monocytosis and the patient was diagnosed with CMML. Our case illustrates the importance of recognizing EMH in a lymph node during routine histological examination, especially in adults. Proliferation of bone marrow elements in a lymph node, in a patient with no known hematologic disorder, should trigger immediate bone marrow evaluation, as this could be the first clue in diagnosing underlying bone marrow disorder.

PubMed Disclaimer

Figures

Figure 1
Figure 1
(a) Paracortical area of the lymph node with extramedullary hematopoiesis (H&E ×200); (b) extramedullary hematopoiesis in the lymph node sinus with prominent red blood cell precursors and megakaryocytes (H&E ×200).
Figure 2
Figure 2
Immunohistochemical stain for Factor VII shows positivity in megakaryocytes (×100).
Figure 3
Figure 3
(a) Hypercellular bone marrow with increase in all three hematopoietic lineages (H&E ×100); (b) prominent dysplasia and clustering of megakaryocytes (H&E ×200).

References

    1. Orazi A., Bennett J. M., Germing U., Brunning R. D., Bain B. J., Thiele J. Chronic myelomonocytic leukemia. In: Swerdlow S. H., Campo E., Harris N. L., et al., editors. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC; 2008. pp. 76–79.
    1. Patnaik M. M., Parikh S. A., Hanson C. A., Tefferi A. Chronic myelomonocytic leukaemia: a concise clinical and pathophysiological review. British Journal of Haematology. 2014;165(3):273–286. doi: 10.1111/bjh.12756. - DOI - PubMed
    1. Groupe Français de Cytogénétique Hématologique. Chronic myelomonocytic leukemia: single entity or heterogeneous disorder?: a prospective multicenter study of 100 patients. Cancer Genetics and Cytogenetics. 1991;55(1):57–65. doi: 10.1016/0165-4608(91)90235-m. - DOI - PubMed
    1. Corcoran N. M., Tsui A., Costello A. J., Bouchier-Hayes D. Unilateral testicular mass in man with chronic myelomonocytic leukemia: unusual presentation of chronic myelomonocytic leukemia sequela. Urology. 2005;65(5):p. 1001. doi: 10.1016/j.urology.2004.11.041. - DOI - PubMed
    1. Hyams E. S., Gupta R., Melamed J., Taneja S. S., Shah O. Renal involvement by chronic myelomonocytic leukemia requiring nephroureterectomy. Reviews in Urology. 2009;11(1):33–37. - PMC - PubMed

LinkOut - more resources